Lithium carbonate, haloperidol, and irreversible brain damage.
D000208:Acute Disease; D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D002254:Carbonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003244:Consciousness Disorders / Q000139:chemically induced; D004357:Drug Synergism; D005260:Female; D005334:Fever / Q000139:chemically induced; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D011605:Psychoses, Substance-Induced / Q000209:etiology*
D002254:Carbonates; D008094:Lithium; D006220:Haloperidol